Asset Management One
ACAD icon

Asset Management One’s Acadia Pharmaceuticals ACAD Stock Holding History

Asset Management One’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-12,474
Closed -$476K – 1022
2017
Q3 		$476K Sell
12,474
-379
-3% -$12.3K ﹤0.01% 925
2017
Q2 		$366K Sell
12,853
-16,811
-57% -$501K ﹤0.01% 899
2017
Q1 		$1.01M Buy
+29,664
New +$1.05M ﹤0.01% 855
2016
Q4 		– Sell
-145,601
Closed -$4.76M – 998
2016
Q3 		$4.76M Sell
145,601
-12,433
-8% -$422K 0.07% 326
2016
Q2 		$5.12M Buy
158,034
+62,466
+65% +$2.09M 0.08% 297
2016
Q1 		$2.48M Buy
95,568
+73,507
+333% +$1.6M 0.04% 538
2015
Q4 		$795K Sell
22,061
-6,770
-23% -$239K 0.01% 936
2015
Q3 		$882K Sell
28,831
-163,205
-85% -$6.79M 0.01% 899
2015
Q2 		$7.65M Sell
192,036
-25,669
-12% -$994K 0.11% 252
2015
Q1 		$7.26M Sell
217,705
-1,492
-0.7% -$51.3K 0.09% 288
2014
Q4 		$7M Buy
219,197
+42,507
+24% +$1.21M 0.09% 290
2014
Q3 		$4.54M Buy
+176,690
New +$4.13M 0.06% 369

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Asset Management One's ACAD Position: Q4 2017 in Review

Asset Management One sold out of Acadia Pharmaceuticals (ACAD) in Q4 2017, closing a stake of 12,474 shares — an estimated $476K sold.

Asset Management One first reported a position in ACAD in Q3 2014 and held it in 12 quarters. The position peaked at $7.65M in Q2 2015. 210 funds tracked by Wall St. Rank hold ACAD as of Q4 2017.

  • Asset Management One reported no remaining Acadia Pharmaceuticals position as of Q4 2017 after selling out during the quarter.
  • Asset Management One sold 12,474 Acadia Pharmaceuticals shares in Q4 2017, an estimated $476K.
  • Asset Management One first reported a position in Acadia Pharmaceuticals in Q3 2014 and held it in 12 quarters.
  • Asset Management One's Acadia Pharmaceuticals position peaked at $7.65M in Q2 2015.
  • 210 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q4 2017.

Based on Asset Management One's 13F filing for Q4 2017, filed 14 Feb 2018.